Publication:
New Opportunities for Endometrial Health by Modifying Uterine Microbial Composition: Present or Future?

dc.contributor.authorMolina, Nerea M
dc.contributor.authorSola-Leyva, Alberto
dc.contributor.authorSaez-Lara, Maria Jose
dc.contributor.authorPlaza-Diaz, Julio
dc.contributor.authorTubić-Pavlović, Aleksandra
dc.contributor.authorRomero, Barbara
dc.contributor.authorClavero, Ana
dc.contributor.authorMozas-Moreno, Juan
dc.contributor.authorFontes, Juan
dc.contributor.authorAltmäe, Signe
dc.date.accessioned2023-02-08T14:45:56Z
dc.date.available2023-02-08T14:45:56Z
dc.date.issued2020-04-11
dc.description.abstractCurrent knowledge suggests that the uterus harbours its own microbiota, where the microbes could influence the uterine functions in health and disease; however, the core uterine microbial composition and the host-microbial relationships remain to be fully elucidated. Different studies are indicating, based on next-generation sequencing techniques, that microbial dysbiosis could be associated with several gynaecological disorders, such as endometriosis, chronic endometritis, dysfunctional menstrual bleeding, endometrial cancer, and infertility. Treatments using antibiotics and probiotics and/or prebiotics for endometrial microbial dysbiosis are being applied. Nevertheless there is no unified protocol for assessing the endometrial dysbiosis and no optimal treatment protocol for the established dysbiosis. With this review we outline the microbes (mostly bacteria) identified in the endometrial microbiome studies, the current treatments offered for bacterial dysbiosis in the clinical setting, and the future possibilities such as pro- and prebiotics and microbial transplants for modifying uterine microbial composition.
dc.identifier.doi10.3390/biom10040593
dc.identifier.essn2218-273X
dc.identifier.pmcPMC7226034
dc.identifier.pmid32290428
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226034/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2218-273X/10/4/593/pdf?version=1586609925
dc.identifier.urihttp://hdl.handle.net/10668/15373
dc.issue.number4
dc.journal.titleBiomolecules
dc.journal.titleabbreviationBiomolecules
dc.language.isoen
dc.organizationIBS
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectantibiotics
dc.subjectchronic endometritis
dc.subjectendometriosis
dc.subjectendometrium
dc.subjectmicrobiome
dc.subjectmicrobiota
dc.subjectprebiotics
dc.subjectprobiotics
dc.subjectuterus
dc.subject.meshDisease
dc.subject.meshEndometrium
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMicrobiota
dc.subject.meshUterine Diseases
dc.subject.meshUterus
dc.titleNew Opportunities for Endometrial Health by Modifying Uterine Microbial Composition: Present or Future?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7226034.pdf
Size:
2.31 MB
Format:
Adobe Portable Document Format